Full set of clinical study reports for the neuraminidase inhibitor Tamiflu (Oseltamivir) produced by Roche and made available to the Cochrane collaboration for the production of their meta-analysis of
PLEASE NOTE, THESE DATA ARE ALSO REFERRED TO IN TWO OTHER ARTICLES. PLEASE SEE http://dx.doi.org/10.1136/bmj.g2547 AND http://dx.doi.org/10.1136/bmj.g2545 FOR MORE INFORMATION. Background: Neuramini
Objectives: An analysis was conducted in Japan to determine the most cost-effective neuraminidase inhibitor for the treatment of influenza virus infections from the healthcare payer’s standpoint. Me
